Alzheimer’s Disease: An Educational Program for Nursing Home, Hospice and Adult Day Care Staff

This comprehensive online course examines the pathophysiology, progression, and symptomatology of Alzheimer’s disease, while equipping healthcare professionals with practical tools to provide compassionate, patient-centered care. Emphasis is placed on effective communication, behavior management, ethical considerations, and interdisciplinary collaboration in nursing homes, hospice environments, and adult day care facilities.

By enrolling in this course, participants will strengthen their clinical approach to dementia care while earning 1 Continuing Education (CE) Contact Hour, automatically reported to CE Broker. Whether you are aiming to improve patient quality of life, fulfill licensing requirements, or stay abreast of the latest best practices, this program provides convenient and relevant training for busy clinicians.

This course provides a thorough exploration of the core elements of Alzheimer’s care, with direct application to real-world healthcare settings. Topics covered include:

• Understanding Alzheimer’s Disease: A review of pathophysiology, risk factors, and clinical progression.
• Behavioral and Psychological Symptoms of Dementia (BPSD): Identification and evidence-based strategies for managing agitation, aggression, wandering, and depression.
• Effective Communication Techniques: Tools to foster trust, reduce confusion, and enhance patient dignity.
• Ethical and Legal Considerations: An overview of decision-making capacity, informed consent, and safety measures.
• Multidisciplinary Care Approaches: The importance of teamwork in developing and implementing individualized care plans.

Important Disclosures:

• Conflict of Interest: Faculty and planners report no relevant financial relationships.
• Commercial Support: This activity received no external commercial funding or sponsorship.
• Non-Endorsement: Accreditation does not imply endorsement of any commercial products or companies.
• Off-Label Product Use: Any mention of off-label drug use is consistent with current clinical guidelines and evidence-based practice.